Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01324765 · ClinicalTrials.gov registry record · Phase 2
Women Overcoming and Managing Adversity Now (WOMAN) Study
A Phase 2 study of Post Traumatic Stress Disorder and PTSD, sponsored by UConn Health.
- Completed
- Registry status
- Phase 2
- Development phase
- 108
- Enrollment target
- 1
- Study location
NCT01324765: Completed Phase 2 study of Post Traumatic Stress Disorder and PTSD, sponsored by UConn Health.
NCT01324765 is a Phase 2 study of Post Traumatic Stress Disorder and PTSD that has completed, run by UConn Health. The registered enrollment target is 108 participants, below the 663-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01324765, a Phase 2 study of Post Traumatic Stress Disorder and PTSD, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 108 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the study is to evaluate the efficacy of a two therapeutic models designed to enhance women's skills for managing reactive emotions in their current lives as well as to educate them about how using these skills can enhance their personal effectiveness and help them to gain control of post-traumatic stress reactions. The interventions adaptations of a manualized psychotherapy that has shown promise with adults with complex Posttraumatic Stress Disorder (PTSD) (Trauma Affect Regulation: Guide for Education and Therapy; TARGET) compared to a supportive group therapy (SGT) that has been found to have modest benefits with women survivors of childhood abuse (Wallis, 2002).
Primary Outcome
PTSD symptom severity, Clinician Administered PTSD Scale
Conditions Studied
Interventions
- BEHAVIORAL TARGET
- BEHAVIORAL SGT
Study Locations (1)
Connecticut
- York Correctional Institution - Niantic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2009-01 |
| Est. Completion | 2010-11 |
| Phase | Phase 2 |
What the finished NCT01324765 record still lists
NCT01324765 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, below the 663-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (84% lower).
The record links to 2 conditions, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which TARGET is the first listed.
NCT01324765 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT01324765 about?
NCT01324765 is a clinical study titled "Women Overcoming and Managing Adversity Now (WOMAN) Study". The goal of the study is to evaluate the efficacy of a two therapeutic models designed to enhance women's skills for managing reactive emotions in their current lives as well as to educate them about how using these skills can enhance their personal effectiveness and help them to gain control of pos...
What is the current status of trial NCT01324765?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 108 participants. The study started on 2009-01. Estimated completion is 2010-11.
What conditions does trial NCT01324765 study?
This clinical trial studies the following conditions: Post Traumatic Stress Disorder, PTSD.
What interventions are being tested in trial NCT01324765?
The interventions under investigation include: TARGET (BEHAVIORAL), SGT (BEHAVIORAL).
Who is sponsoring clinical trial NCT01324765?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01324765 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Traumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01324765's enrollment target sits among peer trials
108 108th of 262 higher than 154 of 262 other Post Traumatic Stress Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Department of Defense PTSD Adaptive Platform Trial - Intervention A - Fluoxetine
RECRUITING · Phase 2
-
Facilitation of Extinction Retention and Reconsolidation Blockade by IV Allopregnanolone in PTSD.
RECRUITING · Phase 2
-
Facilitation of Extinction Retention and Reconsolidation Blockade in PTSD
RECRUITING · Phase 2
-
Department of Defense PTSD Adaptive Platform Trial - Master Protocol
RECRUITING · Phase 2
-
MDMA for AUD/PTSD Comorbidity
RECRUITING · Phase 2
-
Enhancing Transdiagnostic Mechanisms of Cognitive Dyscontrol (R33)
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02703207 · 108 participants · NA
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
- NCT02744677 · 108 participants · NA
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
- NCT02781883 · 108 participants · Phase 2
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
- NCT03848663 · 108 participants · NA
Visual Remapping to Aid Reading With Field Loss
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia